about
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsCommon deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.Myeloid toxicity of cancer treatment.Abnormal expression of C3ORF9 gene in patients with myelodysplastic syndromes.A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosusIncidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes.Incidence and Burden of the Myelodysplastic Syndromes.Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota.Advances in erythropoietic growth factor therapy for myelodysplastic syndromes.Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.Enhanced growth of myelodysplastic colonies in hypoxic conditionsApoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes.Myelodysplastic syndromes: diagnosis and staging.Immunomodulatory effect of mesenchymal stem cells.Benzene and human health: A historical review and appraisal of associations with various diseases.Blastic leukaemias (AML): a biologist's view.Review of therapeutic options and the management of patients with myelodysplastic syndromes.The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression.Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of life.Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients.The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from Turkey.Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene
P2860
Q26751011-AB323DF3-05AE-40AF-A120-B610131DFCFFQ30157922-5127583D-A56B-4995-861F-A600F4B86238Q33416472-273C3548-341E-41BA-96A8-D0AC18440538Q33509916-1792AEC4-E2A2-4F2C-982D-B2A9626CBAA4Q34267853-D6A2E1D1-7903-4E6A-AB92-EE01203FC38DQ34672353-745C6AFC-F3FF-4FEB-B94E-3DE7F28B662FQ35127977-2A69FC6E-D671-4902-9C0D-09B8C8FDC95AQ35604082-F6F02932-DF6A-475A-9855-66574521A259Q35824970-F582F153-B68C-4587-AB93-0239FD700B66Q36006077-FC44770C-CCA7-477D-A349-9DAD58B011D0Q36499044-0B703677-D282-4540-B68B-57D23AB99DD1Q36627226-5CAF3652-B37B-41BD-BB17-8AC15A9FD27AQ36915178-90F4ECB5-AA10-4BC2-9C11-D9FDA747B285Q36916269-888B3DD7-1DD4-4989-9695-62C272516316Q36988558-05ACEA0F-4892-4E42-B53A-7D3AA2781EA9Q37125405-F416A381-45DF-4967-9A3E-E4D68C762912Q37277991-1D447CE4-BB73-4BCE-B1D4-F8EAAF9AECDAQ37758333-F25C8AB7-B949-4379-AEDB-05298677D63BQ37799612-68770430-B66B-4788-9157-8A663356F7E9Q38026774-9BCDE68F-E2BE-40FE-81C8-F5F253D2DF64Q38095121-3E374FCB-F573-4C5F-9A2C-258F83F2FD38Q38615755-BB4B28D2-613E-4A01-B8E9-D13B214DB0BFQ40047158-26C187B5-9B60-4225-BBE0-157AF2BCFE12Q48845975-3B3A5197-390E-47E4-8B51-41AFD42C8253Q50584145-E4EBCAB7-816D-4317-8251-8C1F377E9A47Q53542725-1F8CBF3A-A5EA-45B1-97FF-5FABE575436DQ57465846-1E20CDF8-C7F7-46B7-AA6C-2EB4626E22F0
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Myelodysplasic syndromes: a comprehensive review.
@ast
Myelodysplasic syndromes: a comprehensive review.
@en
type
label
Myelodysplasic syndromes: a comprehensive review.
@ast
Myelodysplasic syndromes: a comprehensive review.
@en
prefLabel
Myelodysplasic syndromes: a comprehensive review.
@ast
Myelodysplasic syndromes: a comprehensive review.
@en
P1433
P1476
Myelodysplasic syndromes: a comprehensive review.
@en
P2093
Daniel V T Catenacci
Gary J Schiller
P304
P356
10.1016/J.BLRE.2005.01.004
P577
2005-11-01T00:00:00Z